Navigation Links
Hospira Expands Board of Directors
Date:5/13/2008

LAKE FOREST, Ill., May 13 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, announced today that Barbara L. Bowles, CFA, has been elected to the company's board of directors. Bowles brings strong investment management and finance expertise from leadership positions held at major multinational consumer goods companies and equity investment advisory firms. The addition of Bowles expands Hospira's board to nine directors, of whom eight are independent.

"Barbara will be an extraordinary addition to the Hospira board," said Christopher B. Begley, chairman and chief executive officer. "Her broad and deep financial knowledge and corporate policy experience will enhance our current board membership and will be extremely helpful in furthering Hospira's longer-term growth goals."

Bowles, 60, recently retired as vice chair of Profit Investment Management, an investment management firm. Previously, she served as chairman, chief executive officer and chief investment officer of The Kenwood Group, Inc. -- an equity investment advisory corporation that she founded in 1989 -- which was acquired by Profit in January 2006. From 1984 to 1989 she served as corporate vice president of Kraft, Inc., and headed its investor relations department. Earlier in her career, Bowles held equity analyst and trust investment management positions at First National Bank of Chicago (now Chase Bank).

Bowles serves as a director of Black & Decker Corporation, Wisconsin Energy Corporation, Children's Memorial Hospital (Chicago), the Chicago Urban League and Hyde Park Bank. She also is a trustee of Fisk University and the Museum of Science and Industry (Chicago), and serves on the University of Chicago Graduate School of Business Advisory Council. In 2003, she was honored with the "Distinguished Alumni Award" from the African American MBA Association of the University of Chicago.

Bowles is currently pursuing her long-time goal of establishing and funding the Landers-Bowles Family Foundation, which will be primarily focused on charity related to education.

A native of Nashville, Tenn., Bowles holds a master's of business administration degree in finance from the University of Chicago Graduate School of Business, and a bachelor's degree in mathematics, with honors, from Fisk University. She has been a Chartered Financial Analyst (CFA) since 1977.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Biogenerics Will Save Billions, Says Hospira CEO
2. Hospiras Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
3. ATS Medical Expands Open Pivot Heart Valve Offerings
4. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
5. BioLife Solutions Expands Scientific Advisory Board
6. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
7. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
8. Pharsight Expands Strategic Consulting Services Team
9. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
10. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
11. AQUISS Expands Into Significant New Territory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... Jan. 16, 2017  Eurofins Genomics today announced the ... more customers to receive their primers in a shorter ... in quality found with other providers. Express oligos are ... at no additional fee. Researchers ... studies, including DNA sequencing, genotyping, site-directed mutagenesis, and cloning. ...
(Date:1/14/2017)... , Jan. 13, 2017  The Alliance for ... in response to FDA final guidance on ... its continued leadership in emphasizing the importance of distinct ... keenly aware of the benefits biosimilars will bring to ... Yet the portion of the Guidance dealing ...
(Date:1/13/2017)... , Jan 13, 2017 Research and Markets ... report to their offering. ... The global biopolymers market to grow at a CAGR of 16.83% during ... and the growth prospects of the global biopolymers market for 2017-2021. To ... sale of sales of biopolymer products. The report also includes a a ...
(Date:1/13/2017)... Island, NY (PRWEB) , ... January 13, 2017 ... ... to meet every cuvette-related demand that it has found among its diverse customer ... cuvettes for use in most brands electroporators including BTX and Bio-Rad. FireflySci ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in ... biometrics market" The mobile biometrics market is expected to ... 49.33 billion by 2022, at a CAGR of 29.3% ... factors such as the growing demand for smart devices, ... transactions. "Software component is expected to grow ...
(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition Market ... Application Area, End User, And Region - Global Forecast to 2021", published by ... 2016 to USD 36.07 Billion by 2021, at a Compound Annual Growth Rate ... ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... an offering of €500.0 million principal amount of its 1.414% ... of its 2.425% senior unsecured notes due 2026. ... on December 13, 2016, subject to the satisfaction of customary closing ... The Company intends to use ...
Breaking Biology News(10 mins):